<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">glazmag</journal-id><journal-title-group><journal-title xml:lang="ru">The EYE ГЛАЗ</journal-title><trans-title-group xml:lang="en"><trans-title>The EYE GLAZ</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2222-4408</issn><issn pub-type="epub">2686-8083</issn><publisher><publisher-name>Академия медицинской оптики и оптометрии</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33791/2222-4408-2019-2-22-30</article-id><article-id custom-type="elpub" pub-id-type="custom">glazmag-109</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ НАУЧНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Эффективность ортокератологической коррекции в сочетании с инстилляциями сверхмалых концентраций атропина при прогрессирующей миопии</article-title><trans-title-group xml:lang="en"><trans-title>Efficacy of myopia control by combination of orthokeratology and instillation of low-concentration atropine</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тарутта</surname><given-names>Е. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Tarutta</surname><given-names>E. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, профессор, начальник отдела патологии рефракции, бинокулярного зрения и офтальмоэргономики</p><p>105062, Москва, ул. Садовая-Черногрязская, д. 14/19</p></bio><bio xml:lang="en"><p>Med.Sc.D., Professor, Head of Refraction pathology, Binocular vision and Ophthalmic Ergonomics Department</p><p>14/19 Sadovaya-Chernogryazskaya St., Moscow, 105062, Russian Federation</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вержанская</surname><given-names>Т. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Verzhanskaya</surname><given-names>T. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Вержанская Татьяна Юрьевна, кандидат медицинских наук, врач-офтальмолог, руководитель направления ортокератологии и контроля миопии</p><p>119049, Москва, Ленинский проспект, д. 2а</p></bio><bio xml:lang="en"><p>Ph.D., Head of Orthokeratology and Control of Myopia Department</p><p>2a Leninsky prospect, Moscow, 119049, Russian Federation</p></bio><email xlink:type="simple">verzt@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «МНИИ ГБ им. Гельмгольца» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FSBI "Helmholtz Moscow Research Institute of Eye Diseases" of the Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Центр ортокератологии, контроля миопии и сложной коррекции зрения «ИМА Вижн»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Centre of Orthokeratology, Myopia Control and Complex Vision Correction, “IMA Vision”</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>02</day><month>10</month><year>2019</year></pub-date><volume>21</volume><issue>2 (126)</issue><fpage>22</fpage><lpage>30</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Академия медицинской оптики и оптометрии, 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Академия медицинской оптики и оптометрии</copyright-holder><copyright-holder xml:lang="en">Академия медицинской оптики и оптометрии</copyright-holder><license xlink:href="https://www.theeyeglaz.com/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.theeyeglaz.com/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.theeyeglaz.com/jour/article/view/109">https://www.theeyeglaz.com/jour/article/view/109</self-uri><abstract><p>В последнее десятилетие в мире отмечается рост близорукости, а в ряде стран она приобрела эпидемический характер. Наиболее эффективными консервативными методами стабилизации миопии являются два направления: применение оптических методов коррекции с воздействием на периферическую рефракцию (в частности, ортокератологической коррекции) и использование фармакологических средств.Цель: оценить эффективность и безопасность контроля миопии у пациентов детского возраста при использовании сочетания двух методов – ортокератологической (ОК) коррекции и инстилляций сверхмалых доз атропина (0,01%). Материал и методы. В проспективное когортное исследование включены 34 пациента (68 глаз) в возрасте от 8 до 14 лет с приобретенной миопией слабой (17 человек, 34 глаза), средней (12 человек, 24 глаза) и высокой (5 человек, 10 глаз) степени. Пациентов обследовали до и через 6, 12 и 18 месяцев после присоединения инстилляций 0,01% раствора атропина к ношению ортокератологических линз (ОКЛ) при продолжающемся процессе прогрессирования миопии. Для оценки степени прогрессирования миопии в динамике оценивали рефракцию, длину переднезадней оси (ПЗО), объективный аккомодационный ответ (ОАО), запас относительной аккомодации (ЗОА), псевдоаккомодацию (ПА) и годовой градиент прогрессирования (ГГП). Результаты. Наиболее заметную эффективность снижения темпов прогрессирования наблюдали при миопии слабой степени – в группе слабой миопии темп ГГП снизился в 3,4 раза к 18 месяцам применения атропина, то есть наступило состояние, близкое к стабилизации процесса прогрессирования миопии, данные достоверны.В группе средней миопии, несмотря на снижение ГГП в 3,7 раза в 6-месячный срок применения атропина, к 12 месяцам начался рост ГГП, который к 18 месяцам продолжился, тем не менее отмечено снижение темпа прогрессирования по сравнению с исходным в 1,3 раза, данные достоверны.В группе высокой миопии динамики изменения величины ГГП в 6-месячный срок применения атропина мы не наблюдали. Далее отмечали постепенное уменьшение темпа прогрессирования миопии, который к году наблюдения достиг снижения в 1,2 раза, а к 1,5 годам применения атропина ГГП замедлился в 1,5 раза по сравнению с исходным, данные достоверны. Очевидно, тормозящий эффект ОКЛ, обусловленный оптическими факторами (а именно периферическим миопическим дефокусом), даже в сочетании с атропином не может остановить прогрессирование высокой миопии, в основе которого лежит нарушение структурных и биомеханических свойств склеральной капсулы.Заключение. На сегодняшний день предварительные результаты не позволяют говорить о 100% эффективности длительной атропинизации сверхмалыми концентрациями. Тем не менее положительный результат наблюдался, исследование продолжается.</p></abstract><trans-abstract xml:lang="en"><p>Majority of reports regarding methods of myopia control are devoted to the use of orthokeratology lenses (OKL) or atropine. The purpose of the study was to estimate the efficacy and safety of using OKL in combination with instillation of 0.01% atropine drops for myopia control in children.</p><sec><title>Material and methods</title><p>Material and methods. Prospective cohort study included 34 patients (68 eyes) aged 8 to 14 years old with acquired myopia. Groups with low (17 patients, 34 eyes), moderate (12 patients, 24 eyes) and high (5 patients, 10 eyes) myopia were identified and examined prior to and 6, 12 and 18 months after adding 0.01% atropine instillations to OKL wearing. To assess the degree of progression of myopia in dynamics the following parameters were evaluated: refraction (by Huvitz MRK 3100P, axial length (AL) by IOL-Master, “Carl Zeiss”, (Germany), amplitude of accommodation (AA) by Grand Seiko WRK-5100K, positive-relative accommodation (PRA), pseudoaccommodation (PA) and annual gradient of progression (AGP). </p></sec><sec><title>Results</title><p>Results. The most noticeable effect was observed in patients with low myopia. In patients with low myopia, the rate of annual progression gradient decreased by 3.4 times by 18th month of atropine use; therefore a condition close to stabilization of myopia progression occurred. The data is statistically significant.</p><p>In patients with moderate myopia, despite the decrease of the AGP within 6-month period of atropine use by 3.7 times, the increase of APG was observed by 12th month of atropine use, which continued until 18th month of observation. In spite of this, in comparison with baseline indices, the decrease in the rate of myopia progression was obtained. The data is statistically significant.</p><p>In patients with high myopia, change in the AGP was not observed within the 6-month period of atropine use; afterwards, a gradual decrease in the rate of myopia progression was noted: AGP decreased by 1.2 times by 12th month. By 18th month of atropine use, AGP decreased by 1.5 times compared to its initial level. The data is statistically significant.</p><p>Evidently, the inhibitory effect of OKL, which is determined by optical factors such as peripheral myopic defocus, even in combination with atropine, is not sufficient to halt the progression of high myopia, because of structural and biomechanical changes of the sclera. </p></sec><sec><title>Conclusion</title><p>Conclusion. Based on the preliminary results obtained, 100% efficacy of a long-term instillation of low-concentration atropine cannot be claimed, how-ever, the positive effect does exist and therefore the study continues.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>миопия</kwd><kwd>ортокератология</kwd><kwd>атропин</kwd><kwd>торможение прогрессирующей миопии</kwd><kwd>длина переднезадней оси</kwd><kwd>дети и подростки</kwd></kwd-group><kwd-group xml:lang="en"><kwd>myopia</kwd><kwd>orthokeratology</kwd><kwd>atropine</kwd><kwd>retardation of myopia progression</kwd><kwd>axial length</kwd><kwd>children and adolescents</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Cooper J., Schulman E., Jamal N. Current status on the development and treatment of myopia. Optometry. 2012;83(5):179-199.</mixed-citation><mixed-citation xml:lang="en">Cooper J., Schulman E., Jamal N. Current status on the development and treatment of myopia. Optometry. 2012;83(5):179-199.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Takahiro Hiraoka, Tetsuhiko Kakita, Fumiki Okamoto et al. Long-term effect of overnight orthokeratology on axial length elongation in child-hood myopia: a 5-year follow-up study. Invest Ophthalmol Vis Sci. 2012;53(7):3913-3919. doi: 10.1167/iovs.11-8453</mixed-citation><mixed-citation xml:lang="en">Takahiro Hiraoka, Tetsuhiko Kakita, Fumiki Okamoto et al. Long-term effect of overnight orthokeratology on axial length elongation in child-hood myopia: a 5-year follow-up study. Invest Ophthalmol Vis Sci. 2012;53(7):3913-3919. doi: 10.1167/iovs.11-8453</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Holden B.A., Fricke T.R., Wilson D.A., Jong M., Nai-doo K.S., Sankaridurg P., Wong T.Y., Naduvilath T.J., Resnikoff S. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042. doi: org/10.1016/j.ophtha.2016.01.006</mixed-citation><mixed-citation xml:lang="en">Holden B.A., Fricke T.R., Wilson D.A., Jong M., Nai-doo K.S., Sankaridurg P., Wong T.Y., Naduvilath T.J., Resnikoff S. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042. doi: org/10.1016/j.ophtha.2016.01.006</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Pararajasegaram R. VISION 2020—the right to sight: from strategies to action. Am J Ophthalmol. 1999;128:359-360.doi: doi.org/10.1016/S0002-9394(99)00251-2</mixed-citation><mixed-citation xml:lang="en">Pararajasegaram R. VISION 2020—the right to sight: from strategies to action. Am J Ophthalmol. 1999;128:359-360. doi: doi.org/10.1016/S0002-9394(99)00251-2</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kinoshita N., Konno Y., Hamada N., Kanda Y., Shimmura-Tomita M., Kakehashi A. Additive effects of orthoke-ratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results. Jpn J Ophthalmol. 2018 Sep;62(5):544-553. doi: 10.1007/s10384-018-0608-3.</mixed-citation><mixed-citation xml:lang="en">Kinoshita N., Konno Y., Hamada N., Kanda Y., Shimmura-Tomita M., Kakehashi A. Additive effects of orthoke-ratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results. Jpn J Ophthalmol. 2018 Sep;62(5):544-553. doi: 10.1007/s10384-018-0608-3.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Z., Huang S., Zhou J., Xiaomei Q., Zhou X., Xue F. Adjunctive effect of orthokeratology and low dose atropine on axial elongation in fast-progressing myopic children-A preliminary retrospective study. Cont Lens Anterior Eye. 2018 Nov 24. pii: S1367-0484(18)30919-6. doi: 10.1016/j.clae.2018.10.026</mixed-citation><mixed-citation xml:lang="en">Chen Z., Huang S., Zhou J., Xiaomei Q., Zhou X., Xue F. Adjunctive effect of orthokeratology and low dose atropine on axial elongation in fast-progressing myopic children-A preliminary retrospective study. Cont Lens Anterior Eye. 2018 Nov 24. pii: S1367-0484(18)30919-6. doi: 10.1016/j.clae.2018.10.026</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wan L., Wei C.C., Chen C.S., Chang C.Y., Lin C.J., Chen J.J., Tien P.T., Lin H.J. The synergistic effects of orthokerato-logy and atropine in slowing the progression of myopia. J Clin Med. 2018;7(9). pii: E259. doi: 10.3390/jcm7090259</mixed-citation><mixed-citation xml:lang="en">Wan L., Wei C.C., Chen C.S., Chang C.Y., Lin C.J., Chen J.J., Tien P.T., Lin H.J. The synergistic effects of orthokerato-logy and atropine in slowing the progression of myopia. J Clin Med. 2018;7(9). pii: E259. doi: 10.3390/jcm7090259</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Cho P., Cheung S.W., Edwards M. The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control. Curr Eye Res. 2005;30(1):71-80.</mixed-citation><mixed-citation xml:lang="en">Cho P., Cheung S.W., Edwards M. The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control. Curr Eye Res. 2005;30(1):71-80.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Eiden B., Davis R.L., Bennett E. et al. Stabilization of Myopia by Accelerated Reshaping Technique (SMART). Global Specialty Lens Symposium, January 2011. doi: 10.15406/aovs.2015.02.00046</mixed-citation><mixed-citation xml:lang="en">Eiden B., Davis R.L., Bennett E. et al. Stabilization of Myopia by Accelerated Reshaping Technique (SMART). Global Specialty Lens Symposium, January 2011. doi: 10.15406/aovs.2015.02.00046</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kakita T., Hiraoka T., Oshika T. Influence of over orthokeratology on axial elongation in childhood myopia. Invest Ophthalmol Vis Sci. 2011;52:2170-2174. doi: 10.1167/iovs.10-5485</mixed-citation><mixed-citation xml:lang="en">Kakita T., Hiraoka T., Oshika T. Influence of over orthokeratology on axial elongation in childhood myopia. Invest Ophthalmol Vis Sci. 2011;52:2170-2174. doi: 10.1167/iovs.10-5485</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Hiraoka T., Kakita T., Okamoto F. et al. Long-term effect of overnight orthokeratology on axial length elongation i childhood myopia: a5-year follow-up study. Invest Ophthalmol Vis Sci. 2012;53:3913-3919. doi: 10.1167/iovs.11-8453</mixed-citation><mixed-citation xml:lang="en">Hiraoka T., Kakita T., Okamoto F. et al. Long-term effect of overnight orthokeratology on axial length elongation i childhood myopia: a5-year follow-up study. Invest Ophthalmol Vis Sci. 2012;53:3913-3919. doi: 10.1167/iovs.11-8453</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Stantodomingo-Rubido J., Villa-Collar C., Gilmartin B. et al. Myopia control with orthokeratology contact lenses in spain: refractive and biometric changes. Invest Ophthalmol Vis Sci. 2012;53:5060-5065. doi: 10.1167/iovs.11-8005</mixed-citation><mixed-citation xml:lang="en">Stantodomingo-Rubido J., Villa-Collar C., Gilmartin B. et al. Myopia control with orthokeratology contact lenses in spain: refractive and biometric changes. Invest Ophthalmol Vis Sci. 2012;53:5060-5065. doi: 10.1167/iovs.11-8005</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Cho P., Cheung S.W. Retardation of myopia in orthokeratology (romio) study: a 2-years randomized clinical trial. Invest Ophthalmol Vis Sci. 2012;53(11):7077-7085. doi: 10.1167/iovs.12-10565</mixed-citation><mixed-citation xml:lang="en">Cho P., Cheung S.W. Retardation of myopia in orthokeratology (romio) study: a 2-years randomized clinical trial. Invest Ophthalmol Vis Sci. 2012;53(11):7077-7085. doi: 10.1167/iovs.12-10565</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Chen C., Cheung S.W., Cho P. Myopia control using toric orthokeratology (TO-SEE study). Invest Ophthalmol Vis Sci. 2013;54(10):6510-6517. doi: 10.1167/iovs.13-12527</mixed-citation><mixed-citation xml:lang="en">Chen C., Cheung S.W., Cho P. Myopia control using toric orthokeratology (TO-SEE study). Invest Ophthalmol Vis Sci. 2013;54(10):6510-6517. doi: 10.1167/iovs.13-12527</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Cheung S.W., Cho P. Validity of axial length measurements for monitoring myopic progression in orthokeratology. Invest Ophthalmol Vis Sci. 2013; 54(3):1613-1615. doi: 10.1167/iovs.12-10434</mixed-citation><mixed-citation xml:lang="en">Cheung S.W., Cho P. Validity of axial length measurements for monitoring myopic progression in orthokeratology. Invest Ophthalmol Vis Sci. 2013; 54(3):1613-1615. doi: 10.1167/iovs.12-10434</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Charm J., Cho P. High myopic-partial reduction orthoke-ratology (HM- PRO): study design. Cont Lens Anterior Eye. 2013;36(4):164-170. doi: org/10.1016/j.clae.2013.02.012</mixed-citation><mixed-citation xml:lang="en">Charm J., Cho P. High myopic-partial reduction orthoke-ratology (HM- PRO): study design. Cont Lens Anterior Eye. 2013;36(4):164-170. doi: org/10.1016/j.clae.2013.02.012</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Нагорский П.Г., Белкина В.В., Глок М.А., Черных В.В. Состояние эпителия и стромы роговицы детей с миопией, использующих ортокератологические линзы (по данным оптической когерентной томографии). Современная оптометрия. 2012;2:18-27.</mixed-citation><mixed-citation xml:lang="en">Nagorskij P.G., Belkina V.V., Glok M.A., Chernyh V.V. The state of epithelium and corneal stroma in children with myopia using orthokeratology lenses (according to data from optical coherence tomography). Sovremennaja optometrija. 2012;2:18- 27. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Тарутта Е.П., Вержанская Т.Ю. Стабилизирующий эффект ортокератологической коррекции миопии (результаты десятилетнего наблюдения). Вестник офтальмологии. 2017;133(1):49-54. doi:org/10.17116/oftalma2017133149-54</mixed-citation><mixed-citation xml:lang="en">Tarutta E.P., Verzhanskaja T.Ju. Stabilizing effect of orthokeratology lenses (ten-year follow-up results). Vestnik oftal’mologii. 2017;133(1):49-54. (In Russ.) doi:org/10.17116/oftalma2017133149-54</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Curtin B.J. The etiology of myopia. The myopias. Basic science and clinical management. Philadelphia: Harper and Row; 1985:222.</mixed-citation><mixed-citation xml:lang="en">Curtin B.J. The etiology of myopia. The myopias. Basic science and clinical management. Philadelphia: Harper and Row; 1985:222.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Chia A., Lu Q.S., Tan D. Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with Atropine 0.01% eyedrops. Ophthalmology. 2016;123(2):391-399. doi:org/10.1016/j.ophtha.2015.07.004</mixed-citation><mixed-citation xml:lang="en">Chia A., Lu Q.S., Tan D. Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with Atropine 0.01% eyedrops. Ophthalmology. 2016;123(2):391-399. doi:org/10.1016/j.ophtha.2015.07.004</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Chew S.J. et. al. Muscarinic antagonists for myopia control. Myopia updates. The 6th International Conference on Myopia, Tokio, 1998;155-162.</mixed-citation><mixed-citation xml:lang="en">Chew S.J. et. al. Muscarinic antagonists for myopia control. Myopia updates. The 6th International Conference on Myopia, Tokio, 1998;155-162.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Khanal S., Turnbull P.R.K., Lee N., Phillips J.R. The effect of atropine on human global flash mfERG responses to retinal defocus. Invest Ophthalmol Vis Sci. 2019;60:218–225. doi:org/10.1167/iovs.18-24600</mixed-citation><mixed-citation xml:lang="en">Khanal S., Turnbull P.R.K., Lee N., Phillips J.R. The effect of atropine on human global flash mfERG responses to retinal defocus. Invest Ophthalmol Vis Sci. 2019;60:218–225. doi:org/10.1167/iovs.18-24600</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Syniuta L.A., Isenberg S.J. Atropine and bifocals can slow the progression of myopia in children. Binocul Vis Strabismus Q. 2001;16:203-208. doi:org/10.1016/j.ophtha.2017.05.032</mixed-citation><mixed-citation xml:lang="en">Syniuta L.A., Isenberg S.J. Atropine and bifocals can slow the progression of myopia in children. Binocul Vis Strabismus Q. 2001;16:203-208. doi:org/10.1016/j.ophtha.2017.05.032</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Jason C. Yam, Yuning Jiang, Shu Min Tang et al. Low-Concentration Atropine for Myopia Progression (LAMP) Study. A randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% Atropine eye drops in myopia control. Ophthalmology. 2019;126:113-124. doi:org/10.1016/j.ophtha.2018.05.029</mixed-citation><mixed-citation xml:lang="en">Jason C. Yam, Yuning Jiang, Shu Min Tang et al. Low-Concentration Atropine for Myopia Progression (LAMP) Study. A randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% Atropine eye drops in myopia control. Ophthalmology 2019;126:113-124. doi:org/10.1016/j.ophtha.2018.05.029</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Smith E.L., 3rd, Huang J., Hung L.F., Blasdel T.L., Humbird T.L., Blockhorst K.H. Hemiretinal form deprivation: evidence for local control of eye growth and refractive development in infant monkeys. Invest Ophthalmol Vis Sci. 2009;50(11):5057-5069.</mixed-citation><mixed-citation xml:lang="en">Smith E.L., 3rd, Huang J., Hung L.F., Blasdel T.L., Humbird T.L., Blockhorst K.H. Hemiretinal form deprivation: evidence for local control of eye growth and refractive development in infant monkeys. Invest Ophthalmol Vis Sci. 2009;50(11):5057-5069.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Тарутта Е.П., Иомдина Е.Н., Толорая Р.Р., Кружкова Г.В. Динамика периферической рефракции и формы глаза на фоне ношения ОК-линз у детей с прогрессирующей миопией. Российский офтальмологический журнал. 2016;9(1):62-66. doi:org/10.21516/2072-0076-2016-9-1-62-66</mixed-citation><mixed-citation xml:lang="en">Tarutta E.P., Iomdina E.N., Toloraja R.R., Kruzhkova G.V. Peripheral refraction and eye shape in children with progressive myopia wearing orthokeratology lenses. Rossijskij oftal’mologicheskij zhurnal. 2016;9(1):62-66. (In Russ.). doi:org/10.21516/2072-0076-2016-9-1-62-66</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Tarutta E., Verzhanskaya T. Parameters of the optikal system of the myopic eye induced by orthokeratological contact lenses and accomodation thereof. Optom Vis Sci. 2009;86(1):56. doi: 10.17116/oftalma2017133149-54</mixed-citation><mixed-citation xml:lang="en">Tarutta E., Verzhanskaya T. Parameters of the optikal system of the myopic eye induced by orthokeratological contact lenses and accomodation thereof. Optom Vis Sci. 2009;86(1):56. doi: 10.17116/oftalma2017133149-54</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Z., Niu L., Xue F., Qu X., Zhou Z., Zhou X., Chu R. Impact of pupil diameter on axial growth in orthokeratology. Optom Vis Sci. 2012;89(11):1636-1640. doi:org/10.1097/OPX.0b013e31826c1831</mixed-citation><mixed-citation xml:lang="en">Chen Z., Niu L., Xue F., Qu X., Zhou Z., Zhou X., Chu R. Impact of pupil diameter on axial growth in orthokeratology. Optom Vis Sci. 2012;89(11):1636-1640. doi:org/10.1097/OPX.0b013e31826c1831</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Тарутта Е.П., Аляева О.О., Вержанская Т.Ю., Милаш С.В. Результаты оценки общего и роговичного астигматизма разными методами у пациентов с миопией, пользующихся ночными ортокератологическими линзами. Вестник офтальмологии. 2013;129(4):59-65. doi:10.17116/oftalma2017133543-48</mixed-citation><mixed-citation xml:lang="en">Tarutta E.P., Aljaeva O.O., Verzhanskaja T.Ju., Milash S.V. Results of corneal and total astigmatism estimation by different methods in myopic patients wearing orthokerato-logy contact lenses. Vestnik oftal’mologii. 2013;129(4):59-65. (In Russ.) doi:10.17116/oftalma2017133543-48</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Тарутта Е.П., Егорова Т.С., Аляева О.О., Вержанская Т.Ю. Офтальмоэргономические и функциональные показатели в оценке эффективности ортокератологической коррекции миопии у детей и подростков. Российский офтальмологический журнал. 2012;5(3):63-66.</mixed-citation><mixed-citation xml:lang="en">Tarutta E.P., Egorova T.S., Aljaeva O.O., Verzhanskaja T.Ju. Ophthalmoergonomic and functional parameters in effectiveness estimation of orthokeratologic correction of myopia in children and teenagers.Rossijskij oftal’molo-gicheskij zhurnal. 2012;5(3):63-66. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Способ оценки объема псевдоаккомодации до и после ортокератологической коррекции миопии: пат. РФ 2500339, Рос. Федерация / Е.П. Тарутта, О.О. Аляева, Т.С. Егорова. № 2012143491; заявл. 11.10.2012; опубл. 10.12.2013, Бюл. № 34.</mixed-citation><mixed-citation xml:lang="en">Method of estimating volume of pseudoaccommodation before and after orthokeratologic myopia correction. Pat. RF 2500339, Russion Federation / E.P. Tarutta, O.O. Aljaeva, T.S. Egorova. N 2012143491; priority 11.10.2012; publ. 10.12.2013, Bjul. № 34. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Zhong Y., Chen Z., Xue F. et al. Corneal power change is predictive of myopia progression in orthokeratology. Optom Vis Sci. 2014;91:404-411. doi: 10.1097/OPX.0000000000000505</mixed-citation><mixed-citation xml:lang="en">Zhong Y., Chen Z., Xue F. et al. Corneal power change is predictive of myopia progression in orthokeratology. Optom Vis Sci. 2014;91:404-411. doi: 10.1097/OPX.0000000000000505</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
